Nasdaq
LTGO
Latigo Biotherapeutics, Inc.
Nasdaq
Latigo Biotherapeutics, Inc.
Latigo Biotherapeutics, Inc. trades under the ticker LTGO on Nasdaq. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing.
This page exists because LTGO is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.